Don’t Miss the Top Stories from NANN's Neonatal News
NANN’s Neonatal News e-newsletter offers subscribers a weekly summary of professional news, trends, and updates. Opt in to have the latest news in neonatal nursing sent directly to your inbox each week. Read top stories, including
- Symptom-triggered medication for neonatal opioid withdrawal yields shorter hospital stays. A study led by researchers at Boston Medical Center found that symptom-triggered medication dosing for neonatal opioid withdrawal syndrome instead of infants receiving a fixed schedule of medication with a long taper reduced the length of their hospital stay. The findings, published in Hospital Pediatrics, indicate that following the novel symptom-triggered approach — developed at BMC — for administering medication could be a more effective intervention for these infants and could help reduce unnecessary medication exposure.
- GE Healthcare recalls 25,000 hospital infant warmer beds due to cracking safety latches. GE Healthcare has recalled two of its infant warmers — bedlike hospital devices designed to radiate heat and track the health of newborns — due to side panels and latches that may crack, break or open, allowing infants to fall. The products include all models of both the Panda iRes, typically used in labor and delivery settings, and the Giraffe warmer, used in neonatal intensive care units.
- Research 'paves the way' for early interventions to prevent childhood inflammatory diseases. A study of newborn infants has identified a compound produced by gut bacteria that appears to predispose certain infants to allergies and asthma later in life. "We have discovered a specific bacterial lipid in the neonatal gut that promotes immune dysfunction associated with allergic asthma and can be used to assess which babies are at risk of developing the disease in childhood" said study senior author Susan Lynch, Ph.D., a professor of medicine at UCSF.